Sweden | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Sweden totalled $ 13.5 billion in 2023. Sales of commodity group 30 from Sweden went up by 2.55% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 338 million (cumulative exports of commodity group 30 from Sweden amounted $13.2 billion in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 6.87% of total exports from Sweden (cumulative merchandise exports from Sweden totalled $ 197 billion in 2023). The share of commodity group 30 in total exports from Sweden increased by 0.166 p.p. compared to 2022 (it was 6.7% in 2022 and cumulative exports from Sweden were equal to $ 197 billion).
Exports of commodity group 30 amounted to 99% of total sales of group 30 "Pharmaceutical products" from Sweden in 2023 (the value of exports of commodity group 30 from Sweden amounted to $13.5 billion in 2023). The share of exports of commodity group 30 in sales of commodity group 30 from Sweden lowered by 0 p.p. compared to 2022 (it was 100% in 2022, and exports of commodity group 30 from Sweden were $13.2 billion).
Where does Sweden export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Sweden in 2023:
- USA with a share of 16.9% (2.3 billion US$)
- Germany with a share of 15.7% (2.14 billion US$)
- China with a share of 9.39% (1.27 billion US$)
- France with a share of 6.49% (882 million US$)
- Norway with a share of 5.13% (698 million US$)
- Austria with a share of 3.9% (530 million US$)
- Russia with a share of 3.54% (481 million US$)
- Italy with a share of 3.07% (417 million US$)
- Spain with a share of 3.06% (415 million US$)
- United Kingdom with a share of 2.81% (382 million US$)
Exports structure of 30 - Pharmaceutical products - from Sweden in 2023 represented by the following main commodity groups:
- 53% (7.25 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 42% (5.8 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 1.18% (161 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
- 1.11% (151 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.795% (108 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.776% (105 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
The value of imports of commodity group 30 "Pharmaceutical products" to Sweden totalled $ 6.46 billion in 2023. Sales of commodity group 30 to Sweden went up by 2.53% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 159 million (the value of imports of commodity group 30 to Sweden was equal to $6.3 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 3.34% of total import flow to Sweden (in 2023, total imports to Sweden amounted to $ 193 billion). The share of commodity group 30 in total imports to Sweden increased by 0.228 p.p. compared to 2022 (it was 3.11% in 2022 and cumulative imports to Sweden were equal to $ 202 billion).
Where does Sweden import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Sweden in 2023:
- Germany with a share of 21% (1.41 billion US$)
- USA with a share of 14.7% (950 million US$)
- Denmark with a share of 14.4% (932 million US$)
- Belgium with a share of 10.3% (666 million US$)
- Netherlands with a share of 9.62% (622 million US$)
- Ireland with a share of 4.42% (285 million US$)
- Italy with a share of 4.24% (274 million US$)
- Switzerland with a share of 3.55% (229 million US$)
- France with a share of 3.51% (226 million US$)
- Poland with a share of 1.89% (122 million US$)
Imports structure of 30 - Pharmaceutical products - to Sweden in 2023 represented by the following main commodity groups:
- 50% (3.28 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 42% (2.74 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 2.24% (145 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 1.93% (125 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.52% (98 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
- 0.924% (59 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
